๐Financials๐PE Ratio๐ฅงShareholding๐ฐDividend๐Quarterlyโ๏ธBalance Sheet๐นP&L๐Cash Flow
DESHRAKPharmaceuticals
Desh Rakshak Aushdhalaya Limited โ PE Ratio & Valuation Analysis
โน27.00
+0.00%
Current P/E31.94xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E18.2x75.3% above avg
โ ๏ธ
0.5% Premium to Industry
DESHRAK P/E 31.94x vs sector avg 31.77x
๐
Historical PE Ratio
| Year | EPS (โน) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | โน0.96 | โน17 | 17.3x |
| 2023 | โน0.14 | โน6 | 46.7x |
| 2022 | โน1.08 | โน5 | 4.6x |
| 2021 | โน0.95 | โน4 | 4.3x |
PE = Year-end closing price รท Diluted EPS. Source: NSE/BSE filings.
๐ก
Understanding Desh Rakshak Aushdhalaya Limited Valuation
Desh Rakshak Aushdhalaya Limited (DESHRAK) currently trades at 31.94x earnings. The Pharmaceuticals sector average PE is 31.77x. DESHRAK commands a premium, reflecting high growth expectations. Historically, DESHRAK has traded at an average PE of 18.2x โ it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only โ not investment advice.
ROE
4.94%
Dividend Yield
0.00%
More on Desh Rakshak Aushdhalaya Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.